1. Biperiden and Mepazine inhibit MALT1 paracaspase activity and tumor growth in pancreatic cancer. (2019) Authors: El Gammal, A.; Konczalla, L.; Scholz, N.; Klemp, C.; Lüdekke, J.; Wolski, A.; Landschulze, D.; Meier, C.; Buchholz, A.; Yao, D.; Wolters-Eisfeld, G.; Hofmann, B.T.; Baukloh, J.-K.; Spriestersbach, S.L.; Grupp, K.; Schumacher, U.; Betzel, C.; Kapis, S.; Nuguid, T.; Steinberg, P. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biperiden and mepazine inhibit MALT1 paracaspase activity and tumor growth in pancreatic cancer. (2019) Authors: El Gammal, A.; Konczalla, L.; Scholz, N.; Klemp, C.; Lüdekke, J.; Wolski, A.; Landschulze, D.; Meier, C.; Buchholz, A.; Yao, D.; Wolters-Eisfeld, G.; Hofmann, B.T.; Baukloh, J.-K.; Spriestersbach, S.L.; Grupp, K.; Schumacher, U.; Betzel, C.; Kapis, S.; Nuguid, T.; Steinberg, P. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Blood fibrinogen levels discriminate low- and high risk intraductal papillary mucinous neoplasms (IPMNs). (2019) Authors: Nentwich, M.F.; Menzel, K.; Reeh, M.; Uzunoglu, F.G.; Ghadban, T.; Bachmann, K.; Schrader, J.; Bockhorn, M.; Izbicki, J.; Perez, D. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Blood fibrinogen levels discriminate low- and high risk intraductal papillary mucinous neoplasms (IPMNs). (2019) Authors: Nentwich, M.F.; Menzel, K.; Reeh, M.; Uzunoglu, F.G.; Ghadban, T.; Bachmann, K.; Schrader, J.; Bockhorn, M.; Izbicki, J.; Perez, D. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S1013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Blood fibrinogen levels discriminate low- and high-risk intraductal papillary mucinous neoplasms (IPMNs). Issue 4 (April 2017) Authors: Nentwich, M.F.; Menzel, K.; Reeh, M.; Uzunoglu, F.G.; Ghadban, T.; Bachmann, K.; Schrader, J.; Bockhorn, M.; Izbicki, J.R.; Perez, D. Journal: European journal of surgical oncology Issue: Volume 43:Issue 4(2017:Apr.) Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Circulating Tumor Cells as a Tumor Stage Independent Biomarker for Diagnosis, Prognosis, and Disease-monitoring in Pancreatic Ductal Adenocarcinoma. (2021) Authors: Nitschke, C.; Markmann, B.; Kropidlowski, J.; Goetz, M.; Tintelnot, J.; Schönlein, M.; Sinn, M.; Tölle, M.; Izbicki, J.; Pantel, K.; Wikman, H.; Uzunoglu, F.G. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical Utility of the 3D Tumoroid Technology in Aggressive Pancreatic Ductal Adenocarcinoma with Nodal Involvement and Poor Differentiation. (2022) Authors: Nitschke, C.; Phan, C.; Markmann, B.; Konczalla, L.; Goetz, M.; Sinn, M.; Thastrup, O.; Izbicki, J.; Sturmheit, T.; Uzunoglu, F.G. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the oesophagus. Issue 4 (6th May 2016) Authors: Ghadban, T.; Miro, J.T.; Trump, F.; Tsui, T.Y.; Uzunoglu, F.G.; Reeh, M.; Gebauer, F.; Bachmann, K.; Wellner, U.; Kalinin, V.; Pantel, K.; Izbicki, J.R.; Vashist, Y.K. Journal: Clinical genetics Issue: Volume 90:Issue 4(2016) Page Start: 343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. Issue 5 (May 2019) Authors: Uzunoglu, F.G.; Welte, M.-N.; Gavazzi, F.; Maggino, L.; Perinel, J.; Salvia, R.; Janot, M.; Reeh, M.; Perez, D.; Montorsi, M.; Zerbi, A.; Adham, M.; Uhl, W.; Bassi, C.; Izbicki, J.R.; Malleo, G.; Bockhorn, M. Journal: European journal of surgical oncology Issue: Volume 45:Issue 5(2019) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Implementing an Enhanced Recovery Protocol for Elective Duodenopancreatectomy: A Long Way to Go. (2021) Authors: Wellge, B.E.; Kuesters, N.; Trepte, C.; Uzunoglu, F.G.; Reeh, M.; Izbicki, J. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗